Replies to post #87381 on Amarantus Bioscience Holdings Inc (AMBS)

[JLM27]

Very irrational price movement at the moment. A month ago we were at .08 on speculation as to who Gerald was sitting next to at a conference. Now we're under .06 with substantial news and a buy rec from a relatively well-respected biotech analyst. But while markets are sometimes irrational in the short term, they tend to become rational in the long term.

Anyway, very happy with the recent developments here and am looking forward to AMBS gaining more traction in the market soon.

[Riskreturn168]

Gerald and His Team's Credibility is on the line. After the debacle that dropped the stock price from .19 cents to .03 cents, management must show they have the wherewithal to execute. Anyone can dilute for temporary relief, but at some point...the goods must be delivered. In our case, management must show we have something of value. We shareholders believe they do, but we're "all in," we have no more money to carry the company. Management must make the case to the market at large...with a big splash...that LymPro and MANF have far greater value than our 28 million market cap suggests. If they can do it...they'll retain their jobs. If they can't...we'll have to find someone that can put out better PRs and DELIVER. I don't think we're at that point now, but if the stock price doesn't stay above .10 cents 20 consecutive days before the end of the year...shareholders are going to be upset!! With that being said, I think they're going to get it done. I think they have some major catalysts to unveil, or else they wouldn't have structured the financing deal the way they did.